Caplyta in Borderline Personality Disorder

NCT05356013 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: Caplyta
DRUG: Placebo

Sponsor

University of Chicago

Collaborators

[object Object]